Promakhos Therapeutics
A therapeutics platform for curing inflammatory disorders
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis. Promakhos Therapeutics is a Y Combinator company (Summer 2021). YC-listed status: Active.
- Website
- promakhos.com
- Location
- Boston, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Promakhos Therapeutics — Drug development platform for non-immunosuppressive therapies that restore natural immune function in inflammatory diseases. · Other
Links
- Y Combinator profileycombinator